losun GMP pharma Co., Limited
云贸汇有限公司
losun GMP pharma Co., Limited (雲貿匯有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622). Its Business Registration Number (BRN) is 78974803, classified as a Private company limited by shares. Incorporated on 2025-10-15, the entity has maintained continuous statutory operations for 1 year, currently holding an active legal status of Live. The registered office is situated at WORKSHOP 3 ON 7/F, LIN FUNG CENTRE, NOS.184-186 TEXACO ROAD TSUEN WAN NEW TERRITORIES, HONG KONG. You may search and order official filing extracts (NAR1/NNC1/ND2A) or request a full commercial due diligence report for Ultimate Beneficial Owner (UBO) penetration.
I. Corporate Profile & Statutory Registry Records
| Official Chinese Name | 雲貿匯有限公司 | Official English Name | losun GMP pharma Co., Limited |
|---|---|---|---|
| Business Reg No. (BRN) | 78974803 | Company Reg No. (CR) | — (No CR Registered) |
| Company Category | Private company limited by shares | Incorporation Date | 2025-10-15 |
| Current Legal Status | Live | Statutory Filing Cycle | 2026-10-15 |
| Registered Office Address |
WORKSHOP 3 ON 7/F, LIN FUNG CENTRE, NOS.184-186 TEXACO ROAD TSUEN WAN NEW TERRITORIES, HONG KONG
|
||
| Significant Controllers (SCR) | Pursuant to Part 12 Division 2A of Cap. 622, SCR records are kept at the registered office. Order our Due Diligence Report to penetrate UBO controllers. | ||
II. Companies Registry Statutory Image Records
Click below to connect with our compliance specialist. The system will immediately query the official Companies Registry database to render the complete archived filing list for this entity.
| Item | Filing Date | Form Ref. | Document Name | Pages | Format | Fee | Action |
|---|---|---|---|---|---|---|---|
| 1 | 2026-10-15 | NAR1 |
NAR1 Statutory Filing
|
17 | ¥28.00 | ||
| 2 | 2025-10-15 | A&A |
A&A Statutory Filing
|
32 | ¥28.00 | ||
| 3 | 2025-10-15 | NNC1 |
NNC1 Statutory Filing
|
22 | ¥28.00 | ||
| 4 | 2025-10-15 | ND2A |
ND2A Statutory Filing
|
4 | ¥28.00 | ||
| 5 | 2025-10-15 | NAR1 |
NAR1 Statutory Filing
|
16 | ¥28.00 |
III. Commercial Due Diligence & Regulatory Risk Screening
Our compliance specialists assist with deep corporate penetration, offshore UBO shareholding structures, court litigation dockets, and global sanctions screening.
IV. Similar Trade Names & Industry Directory
OVOLO GROUP LIMITED
家裕居管理有限公司
NEWTEX INTERNATIONAL HOLD…
新昇国际集团有限公司
Hongkong Myan Technology …
香港觅安科技有限公司
China MetaVision Investme…
中国文旅视听投资集团有限公司
China Middle East Aviatio…
中国中东航空集团有限公司
CHINA MINING & NATIONAL F…
中矿国融控股集团有限公司